Metabolic dysfunction-associated fatty liver disease and cardiovascular disease: A meta-analysis
BackgroundMetabolic dysfunction-associated fatty liver disease [MAFLD, formerly known as nonalcoholic fatty liver disease (NAFLD)] is one of the most important causes of liver disease worldwide, while cardiovascular disease (CVD) is still one of the main causes of morbidity and mortality worldwide,...
Main Authors: | Wen Wen, Hong Li, Chunyi Wang, Chen Chen, Jiake Tang, Mengyun Zhou, Xuwei Hong, Yongran Cheng, Qi Wu, Xingwei Zhang, Zhanhui Feng, Mingwei Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-09-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2022.934225/full |
Similar Items
-
Nonalcoholic Fatty Liver Disease, Liver Fibrosis and Cardiovascular Disease in the Adult US Population
by: Stefano Ciardullo, et al.
Published: (2021-07-01) -
Comprehensive Review of Cardiovascular Disease Risk in Nonalcoholic Fatty Liver Disease
by: Kevan Josloff, et al.
Published: (2022-11-01) -
Transient ischemic attack of the brain as the first link in a decompensatory event chain of cerebro- and cardiovascular incidents in a 68-year-old female patient with radiological features of Fahr’s syndrome – a case report
by: Marcin Kulczyński, et al.
Published: (2018-07-01) -
Transient ischemic attack of the brain as the first link in a decompensatory event chain of cerebro- and cardiovascular incidents in a 68-year-old female patient with radiological features of Fahr’s syndrome – a case report
by: Marcin Kulczyński, et al.
Published: (2018-07-01) -
Impact of the First COVID-19 Wave on French Hospitalizations for Myocardial Infarction and Stroke: A Retrospective Cohort Study
by: Anne-Sophie Mariet, et al.
Published: (2022-10-01)